Emodin derivative E35 and its combination with autophagy inhibitor against acute myeloid leukemia cells in vitro and in vivo
-
Published:2023-11
Issue:2
Volume:432
Page:113780
-
ISSN:0014-4827
-
Container-title:Experimental Cell Research
-
language:en
-
Short-container-title:Experimental Cell Research
Author:
Zhang Li,
Luo Liping,
Zheng Qiaoyun,
Wang Wenfeng,
Huang Zhongyang,
Hu Jianda,
Chen YingyuORCID
Reference53 articles.
1. Self-renewal related signaling in myeloid leukemia stem cells;Heidel;Int. J. Hematol.,2011
2. Relapsed or primary refractory AML: moving past MEC and FLAG-ida;Koenig;Curr. Opin. Hematol.,2020
3. CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial;Lancet;Lancet Haematol,2021
4. Genomic classification and prognosis in acute myeloid leukemia;Papaemmanuil;N. Engl. J. Med.,2016
5. Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial;Jin;Lancet Oncol.,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献